Onco360® Has Been Selected as a National Pharmacy Partner for ZEGFROVY® (sunvozertinib)

BrightSpring Health Services · Partnership · October 26, 2026

Onco360 was chosen by AstraZeneca Pharmaceuticals as a national pharmacy partner to provide Zegfrovy (sunvozertinib) for adult patients with specific types of non-small cell lung cancer.

Read the announcement

AntSpace’s summary of BrightSpring Health Services’s own announcement: read the original.

More updates from BrightSpring Health Services